Candidate selection and organ allocation in liver transplantation

Seminars in Liver Disease

Volumn 29, Issue 1, 2009, Pages 40-52

  Dawwas, Muhammad F ^a   Gimson, Alexander E ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Allocation; Benefit; Cirrhosis; Liver transplantation; Selection; Transplant

Indexed keywords

ARTICLE; CHRONIC LIVER DISEASE; DISEASE SEVERITY; DONOR SELECTION; GRAFT RECIPIENT; GRAFT SURVIVAL; HEALTH CARE SYSTEM; HUMAN; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER GRAFT; LIVER TRANSPLANTATION; MEDICAL ETHICS; ORGAN DONOR; PRIORITY JOURNAL; TREATMENT CONTRAINDICATION; UNITED KINGDOM; UNITED STATES;

CARCINOMA, HEPATOCELLULAR; GREAT BRITAIN; HEALTH SERVICES ACCESSIBILITY; HISTOCOMPATIBILITY; HUMANS; LIVER DISEASES; LIVER FAILURE; LIVER NEOPLASMS; LIVER TRANSPLANTATION; PATIENT SELECTION; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS; TREATMENT OUTCOME; UNITED STATES; WAITING LISTS;

EID: 63049132173     PISSN: 02728087     EISSN: 10988971     Source Type: Journal    
DOI: 10.1055/s-0029-1192054     Document Type: Article

References (133)

1. Merion RM, Schaubel DE, Dykstra DM, Freeman RB, Port FK, Wolfe RA, The survival benefit of liver transplantation. Am J Transplant 2005;5:307-313
2. Freeman RB, Liver allocation: the intent-to-treat approach, Transpl Int 2006;19:270-274
3. Schaubel DE, Sima CS, Goodrich NP, Feng S, Merion RM, The survival benefit of deceased donor liver transplantation as a function of candidate disease severity and donor quality. Am J Transplant 2008;8:419-125
4. Barshes NR, Hacker CS, Freeman RB Jr, Vierling JM, Goss JA. Justice, administrative law, and the transplant clinician:
5. the ethical and legislative basis of a national policy on donor liver allocation, J Contemp Health Law Policy 2007;23: 200-230
6. Dawwas MF, Gimson AE, Lewsey JD, Copley LP, van der Meulen JH. Survival after liver transplantation in the United Kingdom and Ireland compared with the United States, Gut 2007;56:1606-1613
7. Wiesner RH, Freeman RB, Mulligan DC. Liver transplantation for hepatocellular cancer: the impact of the MELD allocation policy. Gastroenterology 2004;127(5, Suppl 1): S261-S267
8. Merion RM, Rush SH, Dykstra DM, Goodrich N, Freeman RB Jr, Wolfe RA. Predicted lifetimes for adult and pediatric split liver versus adult whole liver transplant recipients. Am J Transplant 2004;4(11):1792-1797
9. Foster R, Zimmerman M, Trotter JF, Expanding donor options: marginal, living, and split donors. Clin Liver Dis 2007;11:417-429
10. Coilett D, O'Neill J, Neuberger J. Splitting livers - balancing the gain and the pain. Transpl Int 2008;21:218-222
11. Freeman RB Jr, Survival benefit: quality versus quantity and trade-offs in developing new renal allocation systems. Am J Transplant 2007;7(5):1043-1046
12. Schaubel DE, Guidinger MK, Goodrich NP, Roys EC, Sima CS, Merion RM. Liver transplant benefit; liver allocation models, Am J Transplant 2007;7(suppl 2):192
13. Freeman RB, MELD and the quality of life. Liver Transpl 2005;11:134-136
14. Freeman RB Jr. Mortality risk, behavior, and pediatric liver allocation. Liver Transpl 2006;12:12-15
15. Olsen JA, Theories of justice and their implications for priority setting in health care. J Health Econ 1997;16:625 - 640
16. Dixon J, Welch HG. Priority setting: lessons from Oregon. Lancet 1991;337:891-894
17. Neuberger J, Adams D, MacMaster P, Maidment A, Speed M. Assessing priorities for allocation of donor liver grafts: survey of public and clinicians. BMJ 1998;317:172-175
18. Ubel PA, Jepson C, Baron J, Mohr T, McMorrow S, Asch DA, Allocation of transplantable organs; do people want to punish patients for causing their illness? Liver Transpl 2001; 7:600-607
19. Ratcliffe J, Public preferences for the allocation of donor liver grafts for transplantation. Health Econ 2000;9:137- 148
20. Ho D. When good organs go to bad people, Bioethics 2008; 22:77-83
21. Steinbrook R. Allocating livers - devising a fair system. N Engl J Med 1997;336(6):436-438
22. Ubel PA, Caplan AL. Geographic favoritism in liver transplantation- unfortunate or unfair? N Engl J Med 1998; 339(18):1322-1325
23. HHS/HRSA/HSB/DOT, 2005;OPTN/SRTR Annual Report 1995-2004
24. Organ Procurement and Transplantation Network; final rule revision of comment period and effective dates - HRSA, Extension of comment period and delay of effective date for Organ Procurement and Transplantation Network. Fed Regist 1998;63:16296-16338
25. Institute of Medicine, Analysis of waiting times, In: Committee on Organ Transplantation, Assessing Current Policies and the Potential Impact of the DHHS Final Rule. Washington, DC: National Academy Press; 1999:57-78
26. Freeman RB. MELD: the holy grail of organ allocation? J Hepatol 2005;42:16-20
27. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000;31:864-871
28. Kamath PS, Wiesner R, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33:464-470
29. Wiesner R, Edwards E, Freeman R, et al. Model for end- stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003;124:91-96
30. Cholongitas E, Marelli L, Shusang V, et al. A systematic review of the performance of the model for end-stage liver disease (MELD) in the setting of liver transplantation, liver Transpl 2006;12:1049-1061
31. Kanwal F, Duiai GS, Spiegel BM, Yee HF, Gralnek IM. A comparison of liver transplantation outcomes in the pre - vs. post-MELD eras. Aliment Pharmacol Ther 2005;21(2): 169-177
32. Freeman RB Jr, Wiesner RFi, Roberts JP, McDiarmid S, Dykstra DM, Merion RM. Improving liver allocation: MELD and PELD. Am J Transplant 2004;4(Suppl 9):114- 131
33. UNOS policy management policies. Available at; http://www.unas.org/ policiesandbylaws/policies.asp?resources=true. Accessed October 10, 2008
34. Neuberger J, James O. Guidelines for selection of patients for liver transplantation in the era of donor-organ shortage. Lancet 1999;354:1636-1639
35. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973;60:646-664
36. Christensen E. Prognostic models including the Child- Pugh, MELD and Mayo risk scores-where are we and where should we go? J Hepatol 2004;41:344-350
37. Durand F, Valla D. Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD. J Hepatol 2005;42(suppl 1): S100-S107
38. Barber KM, Pioli S, Blackwell JE, et al Development of a UK score for patients with end-stage liver disease. Hepatology 2007;46:510A
39. Heuman DM, Abou-Assi SG, Habib A, et al. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death. Hepatology 2004;40:802-810
40. Biggins SW, Rodriguez HJ, Bacchetti P, Bass NM, Roberts JP, Terrault NA. Serum sodium predicts mortality in patients listed for liver transplantation. Hepatology 2005; 41:32-39
41. Biggins SW, Kim WR, Terrault NA, et al. Evidence-based incorporation of serum sodium concentration into MELD, Gastroenterology 2006;130:1652-1660
42. Ruf AE, Kremers WK, Chavez LL, Descalzi VI, Podesta LG, Villarnil FG. Addition of serum sodium into the MELD score predicts waiting list mortality" better than MELD alone. Liver Transpl 2005;11:336-343
43. Londoño MC, Cardenas A, Guevara M, et al. MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation. Gut 2007;56(9): 1283-1290
44. Kim WR, Biggins SW, Kremers WK, et al. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med 2008;359:1018-1026
45. Neuberger J, Gimson A, Davies Met alLiver Advisory Group. UK Blood and Transplant. Selection of patients for liver transplantation and allocation of donated livers in the UK. Gut 2008;57:252-257
46. Desschans B, Van Gelder F, Van Hees D, et al. Evolution in allocation rules for renal, hepatic, pancreatic and intestinal grafts. Acta Chir Belg 2008;108:31-34
47. Fontana M, Giostra E, Pilon N, et al. Liver transplantation: new organ allocation system in Switzerland. Rev Med Suisse 2008;4:221-223
48. Teixeira AC, Souza FF, Mota Gde A, Martinelli Ade L, Sankarankutty AK, Silva Ode C. Liver transplantation; expectation with MELD score for liver allocation in Brazil. Acta Cir Bras 2006;21(Suppl 1):12-14
49. Freeman RB Jr. The model for end-stage liver disease comes of age. Clin Liver Dis 2007;11:249-263
50. de la Mata M, Cuende N, Huet J, et al. Model for end-stage liver disease score-based allocation of donors for liver transplantation: a Spanish multicenter experience. Transplantation 2006;82:1429-1435
51. Huo TI, Lin HC, Lee SD. Model for end-stage liver disease and organ allocation in liver transplantation: where are we and where should we go? J Chin Med Assoc 2006;69:193- 198
52. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693-699
53. Freeman RB, Edwards EB, Harper AM. Waiting list removal rates among patients with chronic and malignant liver diseases. Am J Transplant 2006;6(6):1416-1421
54. Freeman RB, Mithoefer A, Ruthazer R, et al, Optimizing staging for hepatocellular carcinoma before liver transplantation: a retrospective analysis of the UNOS/OPTN database. Liver Transpl 2006;12(10):1504-1511
55. Devlin J, O'Grady J. Indications for referral and assessment in adult liver transplantation: a clinical guideline, British Society of Gastroenterology. Gut 1999;45(Suppl 6):VI1-VI22
56. Yao FY, Ferrell L, Bass NM, et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival, Hepatology 2001;33; 1394-1403
57. Yao FY, Bass N, Nikolai B, et al. Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list. Liver Transpl 2002;8:873-883
58. Yao FY, Xiao L, Bass NM, Kerlan R, Ascher NR, Roberts JP. Liver transplantation for hepatocellular carcinoma: Validation of the UCSF expanded criteria based on preoperative imaging. Am J Transplant 2007;7:2587- 2596
59. Bhoori S, Schiavo M, Russo A, Mazzaferro V. First-line treatment for hepatocellular carcinoma: resection or transplantation? Transplant Proc 2007;39:2271-2273
60. Freeman RB, Gish RG, Harper A, et al, Model for End Stage Liver Disease (MELD) exception guidelines: results and recommendations from the MELD Exception Study Group and Conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the standard MELD formula. Liver Transpl 2006;12(suppl 3):S128-S136
61. Freeman RB Jr. Model for end-stage liver disease (MELD) for liver allocation: a 5-year score card, Hepatology 2008;47: 1052-1057
62. Ragni MV, Eghtesad B, Schlesinger KW, Dvorchik I, Fung JJ. Pretransplant survival is shorter in HIV-positive than HIV-negative subjects with end-stage liver disease. Liver Transpl 2005;11:1425-1430
63. Horslen S. Organ allocation for liver-intestine candidates. Liver Transpl 2004;10(10 Suppl 2):S86-S89
64. O'GradyJG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989;97:439-445
65. Kremers WK, van IJperen M, Kim WR, et al. MELD score as a predictor of pretransplant and posttransplant survival in OPTN/UNOS status 1 patients. Hepatology 2004;39:764-779
66. Yantorno SE, Kremers WK, Ruf AE, Trentadue JJ, Podesta LG, Villamil FG. MELD is superior to King's college and Clichy's criteria to assess prognosis in fulminant hepatic failure. Liver Transpl 2007;13:822-828
67. Bernuau J, Goudeau A, Poynard T, et al. Multivariate analysis of prognostic factors in fulminant hepatitis B. Hepatology 1986;6:648-651
68. Bemal W, Wendon J. Liver transplantation in adults with acute liver failure. J Hepatol 2004;40:192-197
69. Sass DA, Shakil AO. Fulminant hepatic failure. Liver Transpl 2005;11:594-605
70. Blei AT. Selection for acute liver failure: have we got it right? Liver Transpl 2005;11(11 Suppl 2):S30-S34
71. Jacob M, Lewsey JD, Sharpin C, Gimson A, Rela M, van der Meulen JH. Systematic review and validation of prognostic models in liver transplantation. Liver Transpl 2005;11: 814-825
72. Lewsey JD, Dawwas M, Copley LP, Gimson A, Van der Meulen JH. Developing a prognostic model for 90-day mortality after liver transplantation based on pretransplant recipient factors. Transplantation 2006;82:898-907
73. Ghobrial RM, Gornbein J, Steadman R, et al. Pretransplant model to predict posttransplant survival in liver transplant patients. Ann Surg 2002;236:315-322
74. loannou GN. Development and validation of a model predicting graft survival after liver transplantation. Liver Transpl 2006;12:1594-1606
75. Plotkin JS, Scott VL, Pinna A, Dobsch BP, De Wolf AM, Kang Y, Morbidity and mortality in patients with coronary artery disease undergoing orthotopic liver transplantation. Liver Transpl Surg 1996;2:426-430
76. Volk ML, Hernandez JC, Lok AS, Marrero JA, A modified Charlson comorbidity index for predicting survival after liver transplantation. Liver Transpl 2007;13:1515-1520
77. Yoo HY, Thuluvath PJ. The effect of insulin-dependent diabetes mellitus on outcome of liver transplantation. Transplantation 2002;74:1007-1012
78. Thuluvath PJ. When is diabetes mellitus a relative or absolute contraindication to liver transplantation? Liver Transpl 2005;11(11 Suppl 2):S25-S29
79. Pikul J, Sharpe MD, Lowndes R, et al. Degree of preoperative malnutrition is predictive of postoperative morbidity and mortality in liver transplant recipients. Transplantation 1994;57:469-472
80. Müller MJ, Lautz H, Plogmann B, Burger M, Korber J, Schmidt F. Energy expenditure and substrate oxidation in patients with cirrhosis: the impact of cause, clinical staging and nutritional state. Hepatology 1992;15:782-794
81. Selberg O, Bottcher J, Tusch G, Pichlmayr R, Henkel E, Muller M. Identification of high- and low-risk patients before liver transplantation; a prospective cohort study of nutritional and metabolic parameters in ISO patients. Hepatology 1997;25:652-657
82. Bilbao I, Armadans L, Lazaro JL, Hidalgo E, Castells L, Margarit C. Predictive factors for early mortality following liver transplantation. Clin Transplant 2003;17:401-411
83. Dawwas MF, Gimson AE, Watson CJ, Allison ME. Modeling the impact of recipient body mass index on post-liver transplant survival: a fractional polynomial approach. Hepatology 2008;48(suppl):554A
84. Jacob M, Copley LP, Lewsey JD, Gimson A, Rela M, van der Meulen JHP. Functional status of patients before liver transplantation as a predictor of posttransplant mortality. Transplantation 2005;80:52-57
85. Yerdel MA, Gunson B, Mirza D, et al. Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome. Transplantation 2000;69:1873-1881
86. Thuluvath PJ, Yoo HY, Thompson RE. A model to predict survival at one month, one year and five years after liver transplantation based on pretransplant clinical characteristics. Liver Transpl 2003;9:527-532
87. Desai NM, Mange KC, Crawford MD, et al. Predicting outcome after liver transplantation: utility of the model for end stage liver disease. Transplantation 2004;77:99-106
88. Dawwas MF, Lewsey JD, Watson CJ, Gimson AE. The impact of serum potassium concentration on mortality after liver transplantation: a cohort multicenter study. Transplantation 2008. In press
89. Londono MC, Guevara M, Rimola A, et al. Hyponatremia impairs early posttransplantation outcome in patients with cirrhosis undergoing liver transplantation. Gastroenterology 2006;130:1135-1143
90. Dawwas MF, Lewsey JD, Neuberger JM, Gimson AE. The impact of serum sodium concentration on mortality after liver transplantation; a cohort multicenter study. Liver Transpl 2007;13:1115-1124
91. Yerdel MA, Gunson B, Mirza D, et al. Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome, Transplantation 2000;69:1873-1881
92. Selvaggi G, Weppler D, Nishida S, et al. Ten-year experience in porto-caval hemitransposition for liver transplantation in the presence of portal vein thrombosis. Am J Transplant 2007;7:454-460
93. Bathgate AJUK Liver Transplant Units, Recommendations for alcohol-related liver disease. Lancet 2006;367:2045- 2046
94. Murray KF, Carithers RL Jr; AASLD. AASLD practice guidelines: evaluation of the patient for liver transplantation. Hepatology 2005;41:1407-1432
95. DiMartini A, Day N, Dew MA, et al. Alcohol consumption patterns and predictors of use following liver transplantation for alcoholic liver disease. Liver Transpl 2006;12(5):813- 820
96. Dew MA, DiMartini AF, Steel J, et al. Meta-analysis of risk for relapse to substance use after transplantation of the liver or other solid organs. Liver Transpl 2008;14(2):159-172
97. Kelly M, Chick J, Gribble R, et al. Predictors of relapse to harmful alcohol after orthotopic liver transplantation. Alcohol Alcohol 2006;41:278-283
98. De Gottardi A, Spahr L, Gelez P, et al. A simple score for predicting alcohol relapse after liver transplantation: results from 387 patients over 15 years. Arch Intern Med 2007;167: 1183-1188
99. Leithead JA, Ferguson JW, Hayes PC. Smoking-related morbidity and mortality following liver transplantation. Liver Transpl 2008;14:1159-1164
100. Koch M, Banys P. Methadone is a medication, not an addiction. Liver Transpl 2002;8:783-786
101. Charpentier KP, Mavanur A. Removing patients from the liver transplant wait list: A survey of US liver transplant programs. Liver Transpl 2008;14:303-307
102. Trotter JF, Brimhall B, Arjal R, Phillips C. Specific laboratory methodologies achieve higher model for endstage liver disease (MELD) scores for patients listed for liver transplantation. Liver Transpl 2004;10:995-1000
103. Cholongitas E, Marelli L, Kerry A, et al. Different methods of creatinine measurement significantly affect MELD scores. Liver Transpl 2007;13(4):523-529
104. Cholongitas E, Marelli L, Kerry A, et al. Female liver transplant recipients with the same GFR as male recipients have lower MELD scores-a systematic bias. Am J Transplant 2007;7(3):685-692
105. Sherman DS, Fish DN, Teitelbaum I. Assessing renal function in cirrhotic patients: problems and pitfalls. Am J Kidney Dis 2003;41:269-278
106. Ravaioli M, Masetti M, Ridolfi L, et al. Laboratory test variability and model for end-stage liver disease score calculation: effect on liver allocation and proposal for adjustment. Transplantation 2007;83(7):919-924
107. Trotter JF, Olson J, Lefkowitz J, Smith AD, Arjal R, Kenison J. Changes in international normalized ratio (INR) and model for endstage liver disease (MELD) based on selection of clinical laboratory. Am J Transplant 2007;7(6): 1624-1628
108. Tripodi A, Chantarangkul V, Primignani M, et al. The international normalized ratio calibrated for cirrhosis (INR(liver)) normalizes prothrombin time results for model for end-stage liver disease calculation. Hepatology 2007; 46(2):520-527
109. Bellest L, Eschwège V, Poupon R, Chazouillères O, Robert A. A modified international normalized ratio as an effective way of prothrombin time standardization in hepatology. Hepatology 2007;46(2):528-534
110. Tripodi A, Chantarangkul V, Mannucci PM. The international normalized ratio to prioritize patients for liver transplantation: problems and possible solutions. J Thromb Haemost 2008;6:243-248
111. Saab S, Ibrahim AB, Shpaner A, et al. MELD fails to measure quality of life in liver transplant candidates. Liver Transpl 2005;11:218-223
112. Yoo HY, Edwin D, Thuluvath PJ. Relationship of the model for end-stage liver disease (MELD) scale to hepatic encephalopathy, neuropsychometric testing, and ascites. Am J Gastroenterol 2003;98:1395-1399
113. Huo TI, Lin HC, Wo JC, et al. Different model for end- stage liver disease score block distributions may have a variable ability for outcome prediction. Transplantation 2005;80(10): 1414-1418
114. Udayakumar N, Subramaniam K, Umashankar L, Verghese J, Jayanthi V. Predictors of mortality in hepatic encephalopathy in acute and chronic liver disease; a preliminary observation. J Clin Gastroenterol 2007;41:922-926
115. Yu JW, Wang GQ, Li SC. Prediction of the prognosis in patients with acute-on-chronic hepatitis using the MELD scoring system. J Gastroenterol Hepatol 2006;21:1519-1524
116. Sharma P, Schaubel DE, Sima CS, Merion RM, Lok AS. Re-weighting the model for end-stage liver disease score components. Gastroenterology 2008;135:1575-1581
117. Ripoll C, Bañares R, Rincón D, et al. Influence of hepatic venous pressure gradient on the prediction of survival of patients with cirrhosis in the MELD era. Hepatology 2005; 42(4):793-801
118. Said A, Williams J, Holden J, et al. Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease. J Hepatol 2004;40(6):897-903
119. Luca A, Angermayr B, Bertolini G, et al. An integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cirrhosis. Liver Transpl 2007;13:1174-1180
120. Stewart CA, Malinchoc M, Kim WR, Kamath PS, Hepatic encephalopathy as a predictor of survival in patients with end-stage liver disease. Liver Transpl 2007;13(10):1366- 1371
121. Heuman DM, Mihas AA, Habib A, et al. MELD-XI: a rational approach to "sickest first" liver transplantation in cirrhotic patients requiring anticoagulant therapy. Liver Transpl 2007;13(l);30-37
122. Feng S, Goodrich NP, Bragg-Gresham JL, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant 2006;6:783-790
123. Dawwas MF, Colfett D, Barber K, Watson CJ, Neuberger JM. Developing a liver transplantation donor risk index in a national registry. Hepatology 2007;46(suppl 1):235A
124. Dawwas MF, Collect D, Barber K, Watson Cj, Neuberger JN, Gimson AE, Should donor organs and recipients be matched in liver transplantation? An analysis of the United Kingdom and Ireland Liver Transplant Database Hepatology" 2007;46(suppl 1):516A
125. Ravaioli M, Grazi GL, Ercolani G, et al. Liver allocation for hepatocellular carcinoma; a European Center policy in the pre-MELD era. Transplantation 2006;81:525-530
126. Segev DL, Maley WR, Simpkins CE, et al. Minimizing risk associated with elderly liver donors by matching to preferred recipients. Hepatology 2007;46:1907-1918
127. Dawwas MF, Allison ME, Watson CJ, Gimson AE. Diabetic donor organs and survival among HCV + liver transplant recipients: a further piece in the jigsaw. Hepatology 2008; 48(suppl):19A
128. Dawwas MF, Watson CJ, Gimson AE. Liver transplant allocation to patients with hepatocellular carcinoma. Hepatology 2008;48(suppl):104A
129. Amin MG, Wolf MP, Tenbrook MA, et al. The under- utilization of expanded criteria donor grafts for deceased donor liver transplantation under the MELD system: a decision analysis. Liver Transpl 2004;10:1468-1475
130. Haydon GH, Hiltunen Y, Lucey MR, et al. Self-organizing maps can determine outcome and match recipients and donors at orthotopic liver transplantation. Transplantation 2005;79:213-218
131. Cucchetti A, Vivarelli M, Heaton ND, et al. Artificial neural network is superior to MELD in predicting mortality of patients with end-stage liver disease. Gut 2007;56:253- 258
132. Shechter SM, Bryce CL, Alagoz O, et al. A clinically based discrete-event simulation of end-stage liver disease and the organ allocation process. Med Decis Making 2005;25:199- 209
133. Thompson D, Waisanen L, Wolfe R, Merion RM, McCullough K, Rodgers A. Simulating the allocation of organs for transplantation. Health Care Manage Sci 2004; 7:331-338